top of page

Groups Feed

View groups and posts below.


This post is from a suggested group

  • As per Data Bridge Market Research analysis, the acaricides market was valued at USD 353.44 million in 2025 and is projected to reach USD 534.24 million by 2033, growing at a CAGR of 5.30% from 2026 to 2033.

  • The market is experiencing consistent growth driven by increasing global demand for sustainable crop protection solutions, advancements in agrochemical formulations, and the rising prevalence of mite and tick infestations across major crop-producing regions.


1 View

This post is from a suggested group

As per Data Bridge Market Research Analysis the rice seeds market was valued at USD 8.37 billion in 2025 and is projected to reach USD 14.44 billion by 2033, growing at a CAGR of 7.05 % from 2026 to 2033. Market growth is primarily driven by the increasing demand for high-yield and climate-resilient rice varieties, rising adoption of certified and hybrid seeds, and growing government initiatives to improve agricultural productivity and food security. Continuous advancements in seed breeding technologies, including hybridization and biotechnology, along with increasing investments in agricultural research and development, are further supporting market expansion.


3 Views

This post is from a suggested group

UK Embolic Protection Devices Market Economic Outlook: Strengthening Stroke Prevention Technologies

The UK Embolic Protection Devices Market economic outlook remains strong as the healthcare system prioritizes reducing complications from cardiovascular and neurovascular procedures. Embolic protection devices (EPDs) play a crucial role during interventions such as transcatheter aortic valve replacement (TAVR) and carotid artery stenting by capturing embolic debris and preventing stroke. With an aging population and a rise in heart-related interventions, demand for EPDs in the UK continues to rise.


Economic outlook data suggest steady investment by both domestic and international manufacturers, focusing on product refinement and cost-efficiency. Regulatory support from agencies such as the MHRA encourages faster product approvals and market entry. Hospitals are incorporating EPDs as standard safety tools in cardiac and vascular procedures, leading to improved outcomes and reduced healthcare burden. Overall, the UK’s embolic protection market shows robust economic growth anchored by innovation and clinical necessity.

FAQsQ1: What is the economic outlook for the UK embolic protection devices…

3 Views

This post is from a suggested group

Welcome to our group Ralph Clements Group! A space for us to connect and share with each other. Start by posting your thoughts, sharing media, or creating a poll.

3 Views
bottom of page